ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2025
Subcortical band heterotopia: electroclinical, radiological, and prognostic features in adults.
Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSubcortical band heterotopia (SBH) is a neuronal migration disorder within the agyria-pachygyria spectrum, ranging from subtle thin bands to diffuse lissencephaly. Adult presentations and prognostic factors remain poorly defined.
objectiveTo characterize the clinical, electrophysiological, radiological features, and long-term outcomes of adults with epilepsy and SBH.
methodsWe retrospectively reviewed 16 adults diagnosed between 2000 and 2024. Demographics (including age at seizure onset), epilepsy risk factors, seizure semiology, treatment histories, and follow-up durations were obtained from hospital records. Interictal and ictal EEG data were gathered from epilepsy center archives and PACS, and MRI studies were analyzed for lesion distribution.
resultsAll 16 patients (12 females; mean age 40 years, range 25-55) remained alive at last follow-up. Seizure onset occurred between 6 months and 15 years of age. Developmental delay was noted in 7 patients (44%). All exhibited pharmacoresistant epilepsy. Interictal EEGs demonstrated focal (predominantly temporal in 11/16, 69%), multifocal, combined focal/multifocal, and generalized epileptiform discharges. Seven underwent video-EEG monitoring, revealing predominantly extratemporal seizure semiology in 6/7 (86%). Levetiracetam and carbamazepine were the most frequently employed antiseizure medications. Four patients received vagus nerve stimulation for drop attacks and generalized seizures; three experienced ≥ 50% seizure reduction.
conclusionThe SBH in adults typically manifests as refractory focal epilepsy with frequent developmental delays. Given the absence of pathognomonic semiology, comprehensive evaluation-including multimodal EEG, high-resolution neuroimaging, and genetic testing when available-is essential for accurate diagnosis and tailored management.
Indexed as
Identifiers
41134416What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.